Travis started Neurobit, which is dedicated to providing a rapid screening solution (Neurospeed) to brain diseases. With detailed course monitoring, recording, and data analyzing, Neurospeed could give an interpretation for doctors to make diagnosis, in the near future, providing early detection and prediction. Travis hopes that Neurospeed can be approved by FDA, CE, TFDA, and CFDA in three years, and then, launched to the market for everyone to use.
Login
